| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +0.0% |
| R&D Expense | $11.4M | -21.1% |
| SG&A Expense | $8.7M | -15.8% |
| Operating Income | -$24.6M | -3.5% |
| Pre-tax Income | -$24.3M | -6.1% |
| Income Tax | -$80K | — |
| Net Income | -$24.3M | -5.7% |
| EPS (Basic) | -$4.98 | -4427.3% |
| EPS (Diluted) | -$4.98 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | +52.2% |
| Short-term Investments | $9.0M | +0.0% |
| Current Assets | $8.0M | -48.4% |
| Total Assets | $12.6M | -49.6% |
| Current Liabilities | $2.7M | +1.7% |
| Total Liabilities | $5.1M | -13.8% |
| Stockholders' Equity | $7.6M | -60.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.9M | -4.0% |
| Capital Expenditures | $218K | +0.0% |
| Investing Cash Flow | $9.2M | -30.5% |
| Financing Cash Flow | $9.2M | — |
| Free Cash Flow | -$16.1M | -3.9% |
| -4427.3% |